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International incidence of psychotic disorders, 2002–17: 
a systematic review and meta-analysis
Hannah E Jongsma, Caitlin Turner, James B Kirkbride, Peter B Jones
Summary
Background The last comprehensive systematic review of the incidence of psychotic disorders was published in 2004. 
New epidemiological data from different settings now permit a broader understanding of global variation. We 
examined the variation in psychosis by demographic characteristics and study method.
Methods For this systematic review and meta-analysis, we searched PubMed, Embase, Web of Science, PsycINFO, and 
bibliographies, and directly contacted first authors. We sought to obtain citations of original research published between 
Jan 1, 2002, and Dec 31, 2017, on incidence of non-organic adult-onset psychotic disorder. We included papers that were 
published or in grey literature and had no language restrictions. Data were extracted from published reports, where 
possible, by sex, age, and ethnic group. Quality of yield was assessed. Data were assessed using univariable random-
effects meta-analysis and meta-regression. We registered our systematic review on PROSPERO, number CRD42018086800.
Findings From 56 721 records identified, 177 met inclusion criteria. The pooled incidence of all psychotic disorders 
was 26·6 per 100 000 person-years (95% CI 22·0–31·7). Heterogeneity was high (I²≥98·5%). Men were at higher risk 
of all psychotic disorders (incidence rate ratio 1·44 [1·27–1·62]) and non-affective disorders (1·60 [1·44–1·77]) than 
women, but not affective psychotic disorders (0·87 [0·75–1·00]). Ethnic minorities were also at excess risk of all 
psychotic disorders (1·75 [1·53–2·00]), including non-affective disorders (1·71 [1·40–2·09]). Meta-regression revealed 
that population registers reported higher rates of non-affective disorders (9·64 [2·72–31·82]), schizophrenia 
(2·51 [1·24–5·21]), and bipolar disorder (4·53 [2·41–8·51]) than first contact study designs.
Interpretation We found marked variation in incidence of psychotic disorders by personal characteristics and place. 
Some geographical variation could be partially explained by differences in case ascertainment methods.
Funding None.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 
license.
Introduction
Psychotic disorders are associated with substantial 
premature mortality,1,2 morbidity,3 and a large social and 
financial burden.4 Yet, research into their distribution 
and determinants has only in the past decade extended 
beyond North America5 and northern Europe6–8 to southern 
Europe,9–12 South America,13 Africa,14,15 and other low-
income and middle-income countries (LMICs).15,16 These 
new data might provide new clues to the determinants of 
the heterogeneity in the incidence of psychotic disorders 
between and within different populations reported in 
previous studies,17,18 aiding both service planning and our 
understanding of cause; both are crucial for planning 
effective public mental health responses. The most recent 
comprehensive systematic review and meta-analysis17 was 
published in 2004 and was restricted to schizophrenia. 
Further meta-analyses have limitations in terms of single 
country coverage,18 search scope, yield and assessment of 
heterogeneity,19 specific population group coverage20,21 or 
coverage of a particular risk factor,22–26 or were also restricted 
to schizophrenia.27
Together, these reviews showed that estimates of the 
incidence of psychotic disorders vary across replicable 
demographic, geographical, and social characteristics. 
Men and young people appear to have an excess risk,27,28 as 
do migrants and their descendants.20,29,30 Settings at higher 
latitude and more urban settings also yield higher in-
cidences.26,31 Socioeconomic deprivation, inequality, and 
instability are also associated with increased incidence.14,32–34 
Earlier meta-analyses17,18,35 found no evidence of variation in 
incidence by study quality or other methodological fea-
tures. Research suggests36,37 that higher incidences are 
derived from population registers (which cover all health-
care contacts within an entire health system) than from 
first-contact studies (which rely on individuals making 
contact with appropriate services). These comparisons 
notwith standing, methodological heterogeneity as an 
explanation for variation in incidences has not been 
investigated widely.
We sought to synthesise the accumulating research on 
the incidence of adult-onset psychotic disorders 
(including affective psychotic disorders) and investigate 
whether sociodemographic factors or methodological 
heterogeneity accounted for any observed variation. 
Consistent with available evidence, we hypothesised that 
incidences would be higher in men, younger people, and 
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those from ethnic minority groups, and in register-based 
studies.
Methods
Search strategy and selection criteria
This systematic review and meta-analysis followed PRISMA 
guidelines38 (appendix pp 2–3), including preregistering 
our protocol with PROSPERO (CRD42018086800) before 
extraction of data. Our method is based on a previous 
systematic review.18
We systematically searched PubMed, PsycINFO, Web 
of Science, and Embase, adapting a previously used 
search strategy18 based on Cochrane Systematic Reviewing 
guidelines.39 This strategy used terms covering psychotic 
disorders and incidence and was adapted for each data-
base (appendix p 4). We searched bibliographies of in-
cluded citations and directly contacted authors to request 
data, where appropriate. We restricted our review to 
studies published between Jan 1, 2002, and Dec 31, 2017. 
We had no restriction on language of publication, study 
design, or publication status, although grey literature was 
only identified via published conference proceedings, 
author correspondence, and bibliographical searches.
Citations were considered eligible if they contained 
incidence data or data from which incidence could be 
derived (numerator and denominator); included patients 
(aged 18–64 years) diagnosed with a first episode of any 
psychotic disorder; were published between Jan 1, 2002, 
and Dec 31, 2017, and were published in the scientific or 
grey literature, online, or in print.
Two authors (HEJ, CT) carried out searches and screened 
the titles found to assess whether they met eligibility 
criteria, with definite or possible titles forwarded to dupli-
cate independent abstract review and, if appropriate, full 
text review. Uncertainties about inclusion were resolved in 
agreement with two senior authors with experience 
in epidemiological research and systematic reviewing 
(JBK, PBJ). The study protocol is available online.
Data analysis
Two authors (HEJ, CT) extracted data. Study-level data 
about study characteristics, rate-level data about incidences, 
and meta-level data on time period, study quality, study 
design, and diagnostic criteria (see below) were included.
The primary outcome was incidence per 
100 000 person-years of all psychotic disorders 
(Inter national Classification of Disease tenth edition 
[ICD-10] = equivalent, F20–33), non-affective disorders 
(F20–29), schizophrenia (F20), affective disorders 
(F30–33), bipolar disorder with psychosis (F30–31), 
psychotic depression (F32–33), or substance-induced 
psychosis (F1X.5). Included studies used a range of 
diagnostic classifications, including ICD-8, ICD-9, and 
ICD–10, and the Diagnostic and Statistical Manual of 
Mental disorders (DSM) versions 3-R and 4, and we 
assumed sufficient commonalities to pool citations 
(appendix p 5).
Where possible, we extracted summary-level incidence 
data on the exposures age, sex, ethnicity, and migrant 
status. Meta-level data on study design, study quality, 
and time period were recorded. Study design was divided 
into first-contact studies (which count the number 
of people attending the relevant service, and include 
first presentation, first diagnosis, first GP record, first 
admission, and first treatment), cohort studies, case-
register studies (with a dedicated national patient register), 
and studies with a general population register covering an 
entire health system. Time period was defined as the 
median year of the case ascertainment period. Where 
incidences were not directly reported, we derived them 
Research in context
Evidence before this study
We searched PubMed and Web of Science (appendix p 4) for 
international systematic reviews and meta-analyses of the 
incidence of non-organic psychotic disorders in the general 
population, published since the last major review of the 
evidence (published in 2004). Our search yielded 156 results, of 
which 14 were meta-analyses. However, these commonly 
examined a single risk factor for psychotic disorders, such as 
migrant status, or synthesised evidence of incidence in a 
particular segment of the population, such as the elderly. 
Only one meta-analysis met all inclusion criteria and 
summarised incidence in the general population, but this 
study provided no assessment of heterogeneity.
Added value of this study
To the best of our knowledge, this study is the first 
comprehensive systematic review and meta-analysis of the 
incidence of non-organic adult-onset psychotic disorders 
done in 16 years and provides an update on the 
epidemiological landscape. For the first time, we also formally 
assessed if incidence of psychotic disorders varies by study 
type. Incidence varied substantially between settings: 
a 10 times variation in incidence was observed across 
diagnostic categories. We also found that studies with routine 
registers reported higher incidences of disorder than studies 
with a service-based design.
Implications of all the available evidence
Variance in the incidence of psychotic disorders worldwide 
arises from both replicable social, demographic, and 
environmental determinants, and from methodological 
heterogeneity. Although most studies continue to be done in 
a handful of countries, future studies across more diverse 
settings will benefit from standardised methods to facilitate 
comparable estimates of incidence across the globe.
See Online for appendix
For study protocol see 
https://www.crd.york.ac.uk/
prospero/display_record.
php?RecordID=86800
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from ancillary information wherever possible. Where 
citations reported overlapping data from the same study 
or population, we used set criteria to establish inclusion 
(appendix p 4).
The full spreadsheet containing all study-level, rate-
level, and meta-level data is available online.
Two independent raters (HEJ, JBK or CT) assessed study 
quality according to seven previously published criteria:18 
designation of a defined catchment area, accurate reporting 
and reliable source of denominator data, population-based 
case finding, standardised research diagnosis used, 
masking (of the clinician) to demographic variables, 
inclusion criteria stated, and inclusion of a leakage study 
(appendix p 4).
We first did a narrative synthesis of the yield. Based on 
previous meta-analyses,17,18 we anticipated high levels of 
heterogeneity and therefore specified use of random-
effects meta-analysis and meta-regression a priori to 
quantify this heterogeneity. When five or more incidences 
could be pooled, we did random-effects meta-analyses 
using the DerSimonian and Laird method,40 grouping 
citations by study design. We transformed incidence rates 
to their natural logarithm and entered into meta-analyses 
with corresponding standard errors (SE)s. If no SE could 
be derived, we retained studies for narrative synthesis 
only. For assessments of differences in incidence by sex 
and ethnicity, we estimated incidence rate ratios (IRRs), 
transformed them to their natural logarithm, and entered 
them into meta-analyses with their corresponding SEs.
We assessed statistical heterogeneity using the Q test 
and quantified using the I² statistic, which identifies the 
proportion of the observed variance that reflects real 
differences in effect size. We examined evidence of small 
study effects (including publication bias) by visual 
inspection of funnel plots and formal testing using 
Egger’s test for which at least 10 estimates were available.41 
We did random-effects meta-regression to explore 
whether heterogeneity was associated with study quality, 
study design, or time period.
We did meta-analyses in Stata (version 13)42 using the 
metan and admetan commands. We did meta-regressions 
using the metareg package, and we did funnel plots and 
Egger’s tests using the metafunnel and metabias packages.
We chose to display pooled estimates to prevent ad-hoc 
summaries of data but considering the high expected 
heterogeneity, the emphasis in interpretation of results is 
on the variation in incidences.
Role of the funding source
There was no funding source for this study.
Results
We retrieved 56 721 records of which 177 met inclusion 
criteria (figure 1; table); 93 (53%) of 177 had sufficient data 
available for meta-analysis and meta-regression. Most 
studies (140 [79%] of 177) were done in Europe, with 14 (8%) 
done in North America. Few studies were done in Asia 
(11 [6%]), the Middle East (seven [4%]), Australia, Latin or 
South America (four [2%] each), or Africa (two [1%]). 
Two citations covered more than one continent.15,55 
Citations examining psychosis in young people (26 [15%]), 
comorbid groups (12 [7%]), the army (seven [4%]), a prison 
population (one [<1%]), and post-partum psychosis 
(five [3%]) are synthesised in the appendix (pp 8–12) 
because they are not representative of the general 
population. The most frequently studied diagnostic 
outcome was schizophrenia (86 [49%]), followed by all 
non-affective disorders (66 [37%]) and all psychotic 
disorders (59 [33%]). Any affective psychotic disorder as an 
outcome was less frequently studied (32 [18%]), although 
we identified 40 (22%) citations of bipolar disorder with 
psychosis and 15 (8%) citations of psychotic depression. 
Six (3%) citations examined sub stance-induced psychosis.
The largest study in this Article48 included 69 690 cases, 
and the smallest study47 identified eight cases. The middle 
For full data spreadsheet see 
https://doi.org/10·17605/OSF.
IO/2T7X4 
Figure 1: PRISMA flowchart
*Citations derived from Kirkbride and colleagues,18 which cover England only from 2002–09. 
12 739 records via PubMed
17 004 records via PsycINFO
13 059 records via Embase
14 263 records via Web of Science
16 records identified via bibliographic search and 
author contact
57 081 records screened 
787 abstracts reviewed for suitability
240 text articles scored against full criteria
177 citations included in qualitative synthesis 
93 citations included in quantitative 
synthesis (meta-analyses)
56 063 excluded
231 duplicates removed
547 excluded
84 citations excluded (insufficient 
information to derive SE)
29 citations identified from previous 
meta-analysis* 
63 excluded
16 no original data
3 no clinical psychosis
40 no incidence data
4 other reasons
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Country Period Type Diagnostic 
confirmation
Diagnostic 
classification
Diagnostic 
outcomes
Number of 
cases
Tsuchiya et al 200261* Denmark 1980–97 First admission ·· ICD-8, ICD-10 Schz Unknown
Hanoeman et al 200262* Surinam 1992–93 First admission Medical records DSM-3-R Schz, schzp 73
Selten et al 200263† Netherlands 1970–92 Case register None ICD-8, ICD-9 Schz Unknown
Baldwin et al 200264‡ Ireland 1995–2000 First contact SCID or medical records DSM-4 FEP 69
Scully et al 200265* Ireland 1995–2000 First contact SCID or medical records ·· FEP 69
Boydell et al 200366* England 1965–97 Case register Case notes plus OPCRIT Combination Schz, 623; 385 
Smith et al 200367‡ Canada 1907–13 First admission Clinical records DSM-4 Schz, schzp, bpd 831
Singh et al 200368 England 2000 First contact Interview, questionnaire, 
case notes
·· FEP 295
Selten et al 200369 Netherlands 1990–96 Case register Discharge summary ICD-9 Bpd, pd 14 749
Cantor-Graae et al 
200370‡
Denmark 1970–98 Population 
register
None ICD-8, ICD-10 Schz 10 244
Baldwin et al 200371‡ Ireland 1995–2002 First contact SCID or clinical records DSM-4 FEP, non-aff, 
schiz, aff, bp, pd, 
other
146
Proctor et al 200472 England 1998–2001 Case register Chart diagnosis ICD-10 FEP, non-aff, schz, 
aff, bp, pd, sip, 
other
227
Sipos et al 200473 Sweden 1989–2001 First admission None ICD-9, ICD-10 Non-aff, schz 1950
Chien et al 200474‡ Taiwan 1997–2001 First contact None ICD-9 Schz 419
Boydell et al 200475* England 1988–97 Combination Case records using OCCPI RDC Schz 222
Veen et al 200476 Netherlands 1997–99 First contact Diagnostic meeting DSM-4 FEP, non-aff, aff, 
oth
181
Singh et al 200477 England 1992–94 First contact Interview, SCAN or SANS 
and OCCPI or OPCRIT
ICD-10 FEP, non-aff, schz, 
aff, sip, oth
168
Sailas et al 200578§ Finland 1984–94 Cohort None Other FEP 71
Harris et al 200579*† Australia ·· First 
presentation
Consensus DSM-4, ICD-10 FEP, schz, aff 94
Sundquist et al 200580‡ Sweden 1997–99 Population 
register
None ICD-9 , ICD-10 FEP, pd 6163
Nager et al 200581¶ Sweden 1986–97 Cohort None ICD-9, ICD-10 FEP 339
Laursen et al 200582‡ Denmark 1952–87 Population 
register
None ICD-8, ICD-10 Schz, schza, bp 18 147
Selten et al 200583 Surinam 2002–03 First contact CASH interview, panel 
discussion
DSM-4 FEP 64
Nixon et al 200584 England 1881–1994 Combination Case notes RDC Schz 41
Qin et al 200585|| Denmark 1950–87 Population 
register
None ICD-8, ICD-10 Non-aff, schz 795
Allardyce et al 200586 Scotland 1989–93 First admission Case record ICD-9 FEP 5838
Cantor-Graae et al 200587 Sweden 1999–2001 First contact Clinical, case records, 
additional data
DSM-4 FEP, non-aff 150
Baldwin et al 200543 Ireland 1995–2003 First contact SCID or clinical diagnosis DSM-4 FEP, non-aff, schz, 
aff, bpd, pd, oth
194
Kennedy et al 2005a88 England 1965–99 Combination Case notes plus OPCRIT DSM-4 Bpd 246
Kennedy et al 2005b89* England 1965–99 Combination Case notes plus OPCRIT DSM-4, ICD-10 Bpd 246; 235 
Lloyd et al 200590‡ England 1997–99 First contact Interview (SCAN, SANS, 
modified PPHS), 
consensus diagnosis
ICD-10 Bpd 75
Leão et al 20068† Sweden 1992–99 Population 
register
None ICD-9, ICD-10 Non-aff Unknown
Bray et al 200691† Canada 1975–85 First contact None ICD-10 Schz 1962
Payne et al 200692 Canada 1993–95 First admission Clinical records ·· Non-aff 146
Drukker et al 200693 Netherlands 1993–2002 Case register None DSM-4 Schz 98
Turner et al 200694** England 1999–2002 First admission Case notes, ratified by 
psychiatrist
ICD-10 Non-aff, schz 62
Mahmmood et al 200695 England 2005–05 First contact Unknown ·· FEP 303
(Table continues on next page)
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Country Period Type Diagnostic 
confirmation
Diagnostic 
classification
Diagnostic 
outcomes
Number of 
cases
(Continued from previous page)
Westman et al 200696‡ Sweden 1997–98 Population 
register
None ICD-9, ICD-10 FEP 10 800
Munk-Olsen et al 200697¶ Denmark 1955–90 Population 
register
None ICD-8, ICD-10 Non-aff, schz 166
Smith et al 200644 Canada 1902–13 First admission Clinical records DSM-4 Schz, schza, schp, 
oth
807
Amminger et al 200698† Australia 1997–2000 First treatment Youth assessment team, 
random sample SCID or 
RPMIP
DSM-4 FEP 1019
Veling et al 20067 Netherlands 1997–2005 First contact Diagnostic meeting DSM-4 Non-aff 181
Morgan et al 200699‡ England 1997–99 First contact Interview (SCAN), case 
notes, consensus meeting
ICD-10 FEP, schz 592
Fearon et al 2006100* England 1997–99 First contact Interview (PSE SCAN), 
case notes (IGC SCAN)
ICD-10 FEP, schz, bpd, pd, 
oth
568
Gould et al 2006101 England 1997–99 First 
presentation
WHO screening for 
psychosis plus OPCRIT
ICD-10 FEP 111
Kirkbride et al 20066 England 1997–99 First contact SCAN, consensus panel DSM-4 FEP, non-aff, schz, 
aff, sip
568
Zipursky et al 2006102 England 1997–99 First contact SCAN, consensus panel DSM-4 FEP, schz Unknown
Li et al 2007103 Sweden 1984–2004 Population 
register
None ICD-9, ICD-10 FEP 40 228
Schimmelmann et al 
2007104*
Australia 1998–2000 First admission SCID and clinical 
diagnosis comparison
DSM-4 FEP 636
Laursen et al 2007105 Denmark 1995–87 Population 
register
None ICD9, ICD-10 Schz, bpd 17 787
Ajdacic-Gross et al 
2007106†
Switzerland 1977–2005 Case register None ICD-8, ICD-9 FEP, schz 7230
Andersen et al 2007107 Norway 1887–2005 First admission Case records ICD-10 Schz, aff 64
Harlow et al 2007108 Sweden 1987–2001 Cohort None ICD-8, ICD-9 Non-aff, schz, 
schza, bpd
2134
Juvonen et al 2007109|| Finland 1950–59 Population 
register
Case notes (2 experts) DSM-4 Schz 807
Cantor-Graae et al 
2007a110‡
Denmark 1986–2006 Population 
register
None ICD-8, ICD-10 Schz 4609
Cantor-Graae et al 
2007b111‡
Denmark 1970–2001 Population 
register
None ICD-8, ICD-10 Schz 10 779
Leão et al 2007112*† Sweden 1995–98 Population 
register
None ICD-9, ICD-10 Non-aff, aff Unknown
Kikbride et al 2007a113 England 1997–99 First contact SCAN, consensus panel ICD-10 FEP, non-aff, aff 295
Menezes et al 200713 Brazil 2002–2004 First contact SCID-I or case notes DSM-4 FEP, non-aff, aff 367
Kirkbride et al 2007b114‡ England 1997–99 First contact SCAN, consensus panel ICD-10 Non-aff, schz, oth 218
Stain et al 2008115† Australia 2001–2005 First contact Case notes Other Oth 308
Boonstra et al 2008116 Netherlands 2002 First contact Clinical diagnosis DSM-4 Non-aff 75
Crebbin et al 2008117* England 1998–2005 Case register Chart diagnosis ICD-10 FEP, schz, pd 540
Farquhar et al 200845 Wales 1875–2005 First admission Case records ICD-10 Schz, schza, aff, 
bpd, pd, oth
579
Pelayo-Teran et al 200810 Spain 2001–05 First contact SCID-I DSM-4 Non-aff 174
Castagnini et al 2008118* Denmark 1996 Case register None ICD-8 Schz, bpd, oth 11 126
Burns et al 200814 South Africa 2005 First 
presentation
Case records DSM-4 FEP 160
Weiser et al 2008119 Israel ·· Population 
register
None ICD-9, ICD-10 Schz 1686
Veling et al 2008120 Netherlands 1997–2005 First contact Diagnostic meeting DSM-4 FEP, non-aff, bpd, 
pd, oth
466
Kirkbride et al 2008a121‡ England 1997–99 First contact SCAN, consensus panel ICD-10 Schz 148
(Table continues on next page)
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Country Period Type Diagnostic 
confirmation
Diagnostic 
classification
Diagnostic 
outcomes
Number of 
cases
(Continued from previous page)
Kirkbride et al 2008b122 England 1996–2000 First contact SCAN, consensus panel DSM-4 FEP, schz, non-aff, 
oth
484
Coid et al 200123 England 1996–2000 First contact SCAN, consensus panel DSM-4 FEP, non-aff, schz, 
aff, oth
484
Grant et al 200124†† USA 2004–05 Cohort Not stated DSM-4 Bpd 263
Crebbin et al 2009125* England 1998–2005 Case register Chart diagnosis ICD-10 Schz, sip 430
Bih et al 2009126*†† Taiwan 1996–2003 Cohort None ICD-9 Bpd 532
Corcoran et al 2009127† Israel 1964–97 Cohort None ICD-10 Non-aff 637
Osby et al 2009128* Sweden 1997–2005 Case register None ICD-10 Bpd 4117
Valdimarsdottir et al 
2009129¶
Sweden 1983–2000 Cohort None ICD-8, ICD-9 FEP 4557
Harlap et al 2009130 Israel 1964–76 Cohort None ICD-10 Schz 637
Reay et al 2009131 England 1998–2005 First contact Chart diagnosis ICD-10 FEP, non-aff, schz, 
aff, bpd, pd
540
Norredam et al 2009132 Denmark 1994–2003 Cohort None ICD-10 Non-aff 1127
Bogren et al 2009133 Sweden 1947–97 First contact Key informants, case files DSM-4 Non-aff, schz, 
schza, aff, bpd
61
Kirkbride et al 2009134‡ England 1978–99 Combination SCAN, consensus 
agreement
ICD-9, ICD-10 FEP, non-aff, schz, 
aff, bpd, pd, sip, 
oth
347
Coid et al 2009123 ·· ·· ·· ·· ·· ·· ··
Cheng et al 2010135† England 2002–2007 First contact Unsure ICD-10 FEP 285
Bogren et al 201046 Sweden 1947–97 First 
presentation
Key informants, case files DSM-4 Non-aff, aff, bpd 108
Zammit et al 2010136‡ Sweden 1972, 1977 First admission None ICD-8, ICD-9 Non-aff, schz 881
Tseng et al 2010137 Taiwan 1996–2001 First 
hospitalisation
None ICD-9 Schz Unknown
Zandi et al 2010138 Netherlands 2002–04 First contact CASH or CASH-CS, 
medical files, consensus 
diagnosis
DSM-4 FEP, schz 77
Norredam et al 2010139‡ Denmark 1994–2003 Cohort None ICD-10 Non-aff 791
Goodman et al 201147** USA ·· First contact Not stated ICD-9 FEP 8
Cowan et al 2011140** USA 2000–09 First 
hospitalisation
None ICD-9 Non-aff 2722
Harris et al 2011141* Wales 1875–2005 First admission Panel assessment of case 
notes
ICD-10 Pd 800
Jorgensen et al 2011142 Sweden 2005 Case register Random sample checked 
by psychiatrist
ICD-10 Non-aff, schz 416
Cheng et al 2011143† England 2002–07 First contact Multidisciplinary 
diagnostic meeting
ICD-10 FEP 285
Kleinhaus et al 2011144† Israel 1964–76 Cohort None ICD-10 Non-aff 860
Benros et al 2011145|| Denmark 1945–96 Population 
register
None ICD-8, ICD-10 Non-aff 39 076
Salokangas et al 2011146 Finland ·· Case register None ICD-8, DSM-3-R, 
ICD-10
Schz 30 032
Schofield et al 2011147 England 1996–2006 First GP record Patient records READ codes FEP 508
Veling et al 2011148 Netherlands 1997–2005 First contact Diagnostic meeting DSM-4 FEP 618
Healy et al 2012149* Wales 1875–2005 First admission Case records, clinical 
diagnosis
ICD-10 Schz, oth 3523
Callaghan et al 2012150* USA 1990–2000 First 
hospitalisation
Not stated ICD-9 Schz 1499
Anderson et al 2012151† Canada 2000–06 First contact None ·· Non-aff 546
Manrique-Garcia et al 
2012152**
Sweden 1969–70 First admission None ICD-8, ICD-9 Non-aff, schz 674
Turola et al 2012153 Italy 1979–2008 First diagnosis Case notes DSM-4, ICD-10 Schz 1759
(Table continues on next page)
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Country Period Type Diagnostic 
confirmation
Diagnostic 
classification
Diagnostic 
outcomes
Number of 
cases
(Continued from previous page)
Werbeloff et al 2012154 Israel 1979–92 Case register None ICD-9 Schz 2335
Nosarti et al 2012155† Sweden 1973–85 First admission None ICD-8 and ICD-9 Non-aff, bpd 886
Gigantesco et al 2012156 Italy 2008 First contact SCID-I, BPRS, GAF in 
duplicate
DSM-4 FEP, bpd 247
Tarricone et al 201211 Italy 2002–09 First contact SCAN, consensus 
diagnosis
ICD-10 FEP, Non-aff, schz, 
aff
163
Kirkbride et al 2012157† England 2009–11 First 
presentation
Clinical diagnoses ICD-10 FEP ··
Hung et al 2013158||†† Taiwan 2000–05 Cohort None ICD-9 Bpd 9711
Peritogiannis et al 
2013159
Greece 2008–09 First contact None ICD-10 FEP 132
Sutterland et al 2013160 Netherlands 1996–2006 First GP record Medical records ICPC Non-aff, schz 293
Cantor-Graae et al 
2013161†‡
Denmark 1995–2010 Population 
register
None ICD-8, ICD-10 Non-aff, schz, 
schza, bpd
13 729
Kroon et al 2013162 Netherlands 1996–2007 First GP record Medical records ICPC Bpd 649
Castagnini et al 2013163‡ Denmark 1995–2008 First diagnosis None ICD-10 Oth 11 126
Hardoon et al 2013164 England 2000–10 First record or 
diagnosis
GP records READ Schz, bpd, oth 10 520
Weibell et al 2013165 Norway 2007–11 First 
presentation
SCID DSM-4 Non-aff, sip 321
Cocchi et al 2014166 Italy 2007–09 First contact ERIaos-CL, 
sociodemographic form, 
HoNOS, BPRS, 
WHO-DAS III
ICD-10 Non-aff 43
Tortelli et al 2014167 France 2005–09 First admission Case notes ICD-10 FEP 258
Hogerzeil et al 201437 Netherlands 2000–05 First contact and 
case register
Diagnostic meeting and 
clinical regularly audited)
DSM-4 Schz 254; 843 
Pedersen et al 2014168* Denmark 1995–2006 Case register None ICD-10 Oth Unknown
Sørensen et al 2014169* Denmark 1993–95 Population 
register
None ICD-8, ICD-10 Schz 17 389
Munk-Olsen et al 
2014170¶
Denmark 1960–95 First treatment None ICD-8, ICD-9 Oth Unknown
Szoke et al 2014171 France 2010–12 First contact Identical procedures, 
regular meetings
DSM-4 FEP, non-aff, aff 133
Bhavsar et al 2014172† England 2000–07 First contact Case notes RDC Schz 405
Omer et al 2014173‡ Ireland 1995–2000 First contact SCID or clinical records DSM-4 FEP 336
Lasalvia et al 20149 Italy 2005–07 First contact Interview, consensus 
diagnosis
ICD-10 FEP, non-aff, schz, 
aff, bpd, pd
558
Veling et al 2014174 Netherlands 1997–2005 First contact Diagnostic meeting DSM-4 FEP, schz, aff, bpd, 
pd, oth
618
Kirkbride et al 201434‡ England 1996–2000 First contact SCAN, consensus 
diagnosis
DSM-4 Non-aff, aff 484
Anderson et al 20155† Canada 1999–2008 Population 
register
Medical records or billing 
claims
Non-aff Unknown
Paksarian et al 2015a175† Denmark 1986–2010 Population 
register
None ICD-8, ICD-10 Non-aff, schz, bpd 15 811
Sørensen et al 2015176 Denmark 1955–67 Population 
register
None ICD-8, ICD-10 Non, aff, schz, aff 15 074; 7562 
Paksarian et al 2015b177 Denmark 1986–2011 Population 
register
None ICD-8, ICD-10 Non-aff, schz, bpd 14 285
Soderlund et al 2015178† Sweden 1955–67 Population 
register
None ICD-10 Non-aff, schz, aff 2322
Medici et al 2015179†† Denmark 1995–2012 Case register None ICD-10 Bpd 15 334
Carlborg et al 2015180†† Sweden 1991–2010 Case register None ICD-10 Bpd 10 273
Tsai et al 2016181||†† Taiwan 2000–07 Cohort None ICD-9 Bpd 202
(Table continues on next page)
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Country Period Type Diagnostic 
confirmation
Diagnostic 
classification
Diagnostic 
outcomes
Number of 
cases
(Continued from previous page)
Chen et al 2015182||†† Taiwan 2000–06 Cohort None ICD-9-CM Bpd, pd 118
Latvala et al 2016183** Sweden 1969–2010 Case register None ICD-8/9/10 Schz, bpd 14 840
Jensen et al 2016184*†† Denmark 1995–2010 Case register None ICD-10 Bpd 12 034
Kuhl et al 2016185* Denmark 2000–12 Population 
register
None ICD-10 Non-aff, schz 23 479
Filatova et al 2016186† Finland 1966–2013 Cohort None ICD-8, ICD-10 Non-aff, schz, 
bpd, oth
295
Chiang et al 201648 Taiwan 1998–2007 First admission None ICD-9-CM FEP 69 690
Nielsen et al 2016187‡ Denmark 1997–2002 Population 
register
None ICD-8, ICD-10 Schz 6927
Kendler et al 201649 Sweden 1972–90 Population 
register
None ICD-9, ICD-10 Non-aff, schz, bpd 22 589
Levine et al 2016a188* Israel 1950–2004 Cohort None ICD-10 Schz 2278
Levine et al 2016b189* Israel 1950–2014 Cohort None ICD-10 Schz 665
Vassos et al 201650‡ Denmark 1995–2006 Population 
register
None ICD-10 FEP, non-aff, bpd 32 983
Sørensen et al 2016190* Denmark 1930–76 Cohort None ICD-8, ICD-10 Schz 4936
Hollander et al 2016191† Sweden 1998–2011 Population 
register
None ICD-10 Non-aff 3704
O’Donoghue et al 2016192 Ireland 2006–11 First 
presentation
SCID DSM-4 FEP 292
Morgan et al 201615 India, Nigeria, 
Trinidad
·· First contact SSP, consensus diagnosis ICD-10 FEP 147
Tarricone et al 2016193 Italy 2002–10 First contact SCAN ICD-10 FEP 187
Szoke et al 2016194 France 2010–14 First contact Unclear—senior review if 
uncertain
DSM-4 Non-aff, aff 212
Mulé et al 201612 Italy 2008–11 First contact SCAN ICD-10 FEP, schz, aff, oth 204
Ramsey et al 201751** USA 2001–14 Cohort None ICD-9 Schz, bpd 24 714
Okkels et al 2017195|| Denmark 1985–2001 Population 
register
None ICD-8, ICD-10 Non-aff, schz, bpd 9329
Vikstrom et al 2017196¶ Sweden 1988–2012 Cohort None ICD-8, ICD-10 Non-aff, bpd 91
Wang et al 2017197|| Taiwan 1997–2007 Cohort None ICD-9 Schz 238
Lin et al 2017198||†† Taiwan 2001–06 Cohort None ICD-9 CM Bpd 183
Marrie et al 2017a199|| Canada 1989–2012 Case register None ICD-9 CM Schz, bpd Unknown
Marrie et al 2017b200|| Canada 1984–2013 Case register None ICD-9 CM Schz, bpd Unknown
Hogerzeil et al 2017201 Netherlands 2000–05 First contact or 
case register
Structured interview or 
clinical, then consensus
DSM-4 Schz 254; 843 
Hoeffding et al 2017202 Denmark 1995–2013 Population 
register
None ICD-8, ICD-10 Non-aff 31 647
Kim et al 201752 South Korea 2002–13 Cohort None ICD-10 Non-aff 9387
Markkula et al 201753 Finland 2011–14 Population 
register
None ICD-10 Non-aff, bpd 2905
Nielsen et al 2017203|| Denmark 1955–99 Population 
register
None ICD-8, ICD-10 Schz 21 305
Schofield et al 2017204 Denmark 1965–97 Population 
register
None ICD-8, ICD-10 Non-aff 26 891
Simon et al 201754 USA 2007–13 First contact None, subset case 
records
ICD-9 FEP 37 843
Kirkbride et al 2017a205† England 2009–13 First contact OPCRIT ICD-10 FEP, non-aff, schz, 
aff, bpd, pd, sip
687
Kirkbride et al 2017b206† England 2009–13 First contact OPCRIT ICD-10 FEP, non-aff, schz, 
aff
687
Schofield et al 2018207‡ Denmark 1965–2013 Population 
register
None ICD-8, ICD-10 Non-aff Unknown
(Table continues on next page)
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year of recruitment varied from 190844 to 2012,53 with most 
citations (105 [59%]) recruiting between approximately 
1995 and 2006. Most studies reported a clearly defined 
catchment area (174 [98%]), clearly listed their inclusion 
criteria (166 [94%]), used accurate denominator data 
(157 [89%]), and employed population-based case-finding 
(135 [76%]). Few studies done used a standardised 
research diagnosis (50 [28%]), did a leakage study (28·5 
[16%]), or used blinding to demographic variables 
(18 [10%]; appendix pp 6–8). 92 (52%) citations reflected 
first contact designs and 76 (43%) used a cohort, case, or 
population register. The remaining nine (5%) studies 
used a combination. 40 (23%) citations used a version of 
the DSM for diagnoses and 118 (67%) used a version of 
ICD. The remaining 19 (11%) used a combination, used 
a different diagnostic system, such as the Research 
Diagnostic Criteria, or it was not reported (three [2%]; 
table). To confirm clinical diagnoses, 21 (12%) citations 
used a structured interview instrument only, 19 (11%) 
reviewed medical records, 14 (8%) used a structured 
interview followed by consensus diagnosis, 13 (7%) used 
only an interview without specifying whether an 
instrument was used, ten (6%) used only a consensus or 
panel discussion, and five (2%) used a chart or clinical 
diagnoses. The remaining citations either relied solely on 
clinical diagnoses in registry data (85 [48%]), or 
information was not stated (ten [6%]; table).
We included 44 separate estimates of the incidence of 
all psychotic disorders derived from 27 citations, including 
estimates from multicentre studies (figure 2). Incidence 
varied around 15 times, from 6·3 per 100 000 person-years 
(95% CI 4·5–8·8) in Santiago (Spain)55 to 90·0 (88·3–91·8) 
in the USA.54 The overall pooled incidence of all psy-
chotic disorders was 26·6 per 100 000 person-years 
(22·0–31·7).
Incidence of non-affective disorders was available from 
47 incidences derived from 28 citations (figure 3). 
Incidence varied almost 30 times, from 5·2 per 
100 000 years (95% CI 3·7–7·4) in Santiago55 to 148·4 
(142·7–154·4) in Finland.53 The overall pooled incidence 
was 18·7 per 100 000 person-years (14·8–23·6), but this 
incidence was lower in first-contact studies at 17·4 
(14·6–20·8) compared with population register studies 
(pooled incidence rate 90·9 [34·5–237·5]; figure 3). 
The incidence of schizophrenia was available from 
36 incidences from 26 citations and varied from 2·7 per 
100 000 person-years (1·4–5·3) in Cavan-Monaghan 
(Ireland)43 to 75·9 (74·4–77·5) in South Korea.52 Pooled 
incidence was lower in first contact studies (13·1 per 
100 000 person-years [9·0–15·0]) than in population 
registers (32·8 [23·2–46·5]; figure 4).
We pooled 34 estimates of the incidence of affective 
psychotic disorders from 16 citations. Incidence varied 
from 0·9 per 100 000 person-years (95% CI 0·4–2·2) in 
Santiago55 to 17·0 (10·8–26·6) in Lundby (Sweden).46 The 
overall pooled rate was 4·6 per 100 000 person-years 
(3·1–6·8; figure 5). 24 estimates of the incidence 
of bipolar disorder were included in a meta-analysis, 
derived from 15 citations. Incidence varied from 
1·4 per 100 000 person-years (1·0–2·0) in Wales45 to 
28·5 (28·0–29·1) in Sweden,49 and was higher in 
population registers (15·1 [10·2–22·3]) than first contact 
Country Period Type Diagnostic 
confirmation
Diagnostic 
classification
Diagnostic 
outcomes
Number of 
cases
(Continued from previous page)
Nyberg et al 2018208**‡‡ Sweden 1968–2005 Cohort None ICD-8, ICD-9, 
ICD-10
Non-aff 4641
Barghadouch et al 
2018209†‡‡
Denmark 1993–2000 Cohort None ICD-10 Non-aff 392
Richardson et al 
2018210†‡‡
England 2009–13 First contact OPCRIT ICD-10 FEP, non-aff, schz, 
aff
0687
Jongsma et al 201855 England, 
Netherlands, 
France, Spain, 
Italy, Brazil
2005–15 First contact SCAN, CASH, DIGS, SID, 
or case notes—OPCRIT
ICD-10 FEP, non-aff, aff 2774
All references up to and including 60 are found in the reference list of the main article. References from 61 onwards are found in the appendix (pp 35–43). Aff=affective 
psychosis. Bpd=bipolar disorder. BPRS=Brief Psychiatric Rating Scale. CASH=Comprehensive Assessment of Symptoms and History. CASH-CS=CASH-Culturally Sensitive. 
DIGS=Diagnostic Interview for Genetic Studies. DSM=Diagnostic and Statistical Manual. ERIaos-CL=Early Recognition Inventory Retrospective Assessment of Symptoms 
checklist. FEP=all first episode psychosis. GAF=Global Assessment of Functioning. HoNOS=Health of the Nations Outcome Scale. ICD=International Classification of Disease. 
Non-aff=non-affective psychosis. OCCPI=Operational Criteria Checklist for Psychotic Illness. OPCRIT=Operational Criteria Checklist for Psychotic Illness. Oth=other. 
Pd=psychotic depression. PPHS=Personal and Psychiatric History Schedule. PSE=Present State Examination. RDC=Research Diagnostic Criteria. RPMIP=Royal Park 
Multidiagnostic Instrument for Psychosis. SANS=Scale for the Assessment of Negative Symptoms. SCAN=Schedules Clinical Assessment Neuropsychiatry. 
Schz=schizophrenia. Schzp=schizophreniform disorder. Schza=schizoaffective disorder. SCID=Structural Clinical Interview for DSM-4. SCID-I=SCID-Axis I disorders. 
Sip=substance-induced psychosis. SID=Structured Interview for DSM-4. SSP=Screening Schedule for Psychosis. WHO-DAS III=WHO Disability Assessment Schedule. 
*Citations with insufficient data to include in quantitative analyses. †Citations only covering young people (<40 years). ‡Citations only containing information covered in 
more detail in other citations. §Citations covering a prison population. ¶Citations covering post-partum psychosis. ||Citations covering comorbid populations. **Citations 
covering the army only. ††Citations including psychotic bipolar disorder, but where this can’t be clearly differentiated from bipolar disorder more widely (not included in 
analyses). ‡‡Published online in 2017.
Table: Study characteristics of included citations
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studies (3·6 [2·0–6·5]; figure 6). Insufficient citations 
were available to pool rates for other outcomes.
Pooled estimates of the incidence of all psychotic 
disorders were similar across high-income and LMICs 
(appendix pp 11–16), though heterogeneity was sub-
stantial in both sets of data; formal comparisons were 
hampered by insufficient studies in LMICs.
For all psychotic disorders, 26 estimates of IRRs in 
men compared with women were available from 
10 citations, with a pooled IRR of 1·44 (95% CI 1·27–1·62). 
A similar pattern was observed for non-affective 
psychoses (1·60 [1·44–1·77]; derived from 27 estimates 
using 11 citations) and schizophrenia (1·70 [1·46–1·97]; 
derived from 11 estimates using 11 citations). No excess 
risk in men was found for affective disorders (IRR 0·87 
[0·75–1·00]; p=0·07; derived from 20 estimates using 
six citations) or for psychotic bipolar disorder (0·90 
[0·73–1·11]; derived from five estimates; appendix p 17). 
Insufficient citations were available to pool IRRs for 
other outcomes.
Migrants and their descendants were at excess risk of 
all psychotic disorders, non-affective disorders, and 
schizo phrenia (insufficient citations were available to 
synthesise results for other diagnostic outcomes). When 
pooling all migrant groups to a binary majority or 
minority division, 22 estimates from seven citations were 
available to pool IRRs for all psychotic disorders (pooled 
IRR 1·75 [95% CI 1·53–2·00]). The pooled IRR for non-
affective disorders was 1·71 (1·40–2·09), derived using 
28 estimates from thirteen citations. The pooled IRR for 
schizophrenia was 1·41 (1·15–1·75), derived using 
six estimates (appendix p 18). Risk was not equitably 
distributed across ethnic minority groups (appendix 
pp 19–21).
We did not pool estimates by age group because of the 
large variety of age groups used. Nonetheless, we 
observed an overall pattern of higher incidence in younger 
age groups (appendix pp 22–24). For example, in the 
multinational EU-GEI study55 incidence of all first episode 
psychosis ranged from 44·2 per 100 000 person-years 
(95% CI 42·2–46·2) in people aged 18–24 years to 
5·5 (3·2–7·7) in people aged 60–64 years.55
We found some evidence that study design was 
associated with variation in incidence. Population 
registers had higher incidences of non-affective disorders 
(IRR 9·64 [2·72–31·82]), schizophrenia (2·54 [1·24–5·21]), 
and bipolar disorder (4·53 [2·41–8·51]) than first contact 
studies. Incidence of schizophrenia was also elevated in 
cohort studies (3·10 [1·12–8·53]) and case registers 
(3·12 [1·33–7·29]). Cohort studies (0·43 [0·20–0·93]) and 
population registers (0·42 [0·22–0·83]) recorded lower 
IRRs by minority status for non-affective disorders than 
first contact designs, but we found no differences by 
study design in IRRs for any other exposure or outcome 
association. We found little evidence that study quality 
and time period were associated with changes in 
incidence or IRR (appendix pp 25–28).
Heterogeneity was high across study outcomes 
(I² ≥98·5%; figures 2–6). Small study effects, as evidenced 
by Egger’s test, were shown in the overall meta-analyses 
of incidences of all psychotic disorders (β –7·53 [SE 3·14]; 
p=0·021), non-affective disorders (–14·55 [2·46]; p<0·001), 
schizophrenia (–11·78 [5·52]; p=0·041), affective disorders 
(7·72 [1·60]; p<0·001), and bipolar disorder (–14·97 [2·78]; 
p<0·001). They were also found in analyses by sex for all 
psychotic disorders (2·16 [0·44]; p<0·001) and affective 
disorders (0·90 [0·24]; p=0·001), but not for other 
diagnostic outcomes or for analyses by ethnic group 
(appendix pp 29–32). Post-hoc sensitivity analyses 
Figure 2: Incidence of all psychotic disorders
References from 61 onwards are found in the appendix (pp 35–43). IR=incidence rates. Note: weights are from 
random effects analysis. 
NotesCountry IR (95% CI)
Overall (I2=99·6%, p=0·000)
Allardyce et al (2005)86
Weibell et al (2013)165
Jongsma et al (2018)55
Jongsma et al (2018)55
Morgan et al (2016)15
Jongsma et al (2018)55
Jongsma et al (2018)55
Kirkbride et al (2006)6
Reay et al (2009)131
Simon et al (2017)54
Menezes et al (2007)13
Combination
Jongsma et al (2018)55
Morgan et al (2016)15
Baldwin et al (2005)43
Gould et al (2006)101
Burns et al (2008)14
Nixon et al (2005)84
Kirkbride et al (2006)6
Jongsma et al (2018)55
O’Donoghue et al (2016)192
Subtotal  (I2=99·7%, p=0·000)
Jongsma et al (2018)55
Tortelli et al (2014)167
Peritogiannis et al (2013)159
Jongsma et al (2018)55
Jongsma et al (2018)55
Morgan et al (2016)15
Kirkbride et al (2006)6
Jongsma et al (2018)55
Chiang et al (2016)48
Subtotal
Bogren et al (2009)133
Singh et al (2004)77
Jongsma et al (2018)55
Jongsma et al (2018)55
Veling et al (2011)148
Zandi et al (2010)138
Bogren et al (2009)133
Jongsma et al (2018)55
Singh et al (2003)68
Jongsma et al (2018)55
Jongsma et al (2018)55
Schofield et al (2011)147
Jongsma et al (2018)55
Coid et al (2008)123
Jongsma et al (2018)55
Scotland
Norway
Spain
Spain
Trinidad
England
England
England
England
USA
Brazil
France
Nigeria
Ireland
England
South Africa
England
England
Netherlands
Ireland
Italy
France
Greece
Brazil
Italy
India
England
Spain
Taiwan
Sweden
England
Spain
Spain
Netherlands
Netherlands
Sweden
Netherlands
England
France
Spain
England
Italy
England
France
Madrid
Valencia
Cambridgeshire
Southeast London
Southeast London
Puy−de−Dome
Bristol
Amsterdam
Veneto
Ribeirao Preto
Bologna
Nottingham
Barcelona
1957 cohort
Santiago
Cuenca
CASH
1947 cohort
Gouda and Voorhout
Paris
Oviedo
Palermo
Val−de−Marne
26·59 (22·01–32·13)
23·34 (22·88–23·80)
24·05 (20·56–28·13)
21·54 (17·36–26·72)
15·96 (12·37–20·59
27·11 (19·43–37·83)
17·12 (15·22–19·25)
61·56 (54·73–69·24)
54·60 (48·54–61·41)
30·88 (28·55–33·39
90·02 (88·27–91·80)
15·80 (14·32–17·43)
18·54 (13·82–24·88)
36·97 (28·10–48·64)
31·50 (27·46–36·13)
29·67 (23·45–37·53)
31·50 (26·93–36·85)
20·91 (17·87–24·45)
22·20 (17·21–28·64)
46·53 (41·36–52·33)
21·98 (19·54–24·72)
26·74 (22·09–32·38)
20·70 (17·01–25·18)
39·65 (35·25–44·59
29·96 (25·12–35·74)
21·54 (19·92–23·30)
17·64 (15·08–20·63)
31·19 (24·17–40·24)
25·03 (21·82–28·71)
12·18 (10·01–14·82)
46·06 (45·17–46·97)
20·91 (17·87–24·45)
32·79 (24·43–43·99
21·12 (18·05–24·70)
6·30 (4·51–8·79)
13·74 (9·47–19·93)
33·12 (30·62–35·82)
21·98 (17·03–28·35)
37·71 (28·11–50·60)
21·76 (18·60–25·45)
20·91 (18·59–23·51)
44·70 (37·47–53·32)
17·64 (14·22–21·88)
48·91 (45·22–52·90)
11·25 (9·80–12·90)
58·56 (53·09–64·59
41·68 (36·34–47·81)
20 40 6080
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supported some remaining small study effects within 
first contact designs (appendix p 32).
Discussion
Our systematic review identified 177 citations containing 
data on the incidence of psychotic disorders published 
since 2002. This yield is considerably higher than reported 
in another systematic review19 and was marked by 
substantial heterogeneity in incidence across all major 
psychotic disorders. Although we found no evidence that 
incidences varied with study quality or time period, we did 
observe strong evidence of higher incidence rates reported 
in register-based or cohort-based study designs than in 
first-contact studies. Given that register-based or cohort-
based studies are often done with whole population 
samples (ie, the USA,51,54 Sweden,49 Denmark,50 Taiwan48), 
this difference was consistent with our evidence of small 
study effects, whereby smaller studies tended to estimate 
lower incidence rates. Together with the high levels of 
statistical heterogeneity observed in our meta-analyses, 
our results suggest that methodological variation might 
partially obscure true heterogeneity in the incidence of 
psychotic disorders. Nonetheless, as previously established, 
we found strong evidence of higher incidences of all first 
Figure 3: Incidence of non-affective disorders
References from 61 onwards are found in the appendix (pp 35–43). IR=incidence rates. Note: weights are from random effects analysis.
NotesCountry IR (95% CI)
2380·00421
Overall  (I2=99·6%, p=0·000)
Jongsma et al (2018)55
Jongsma et al (2018)55
Sipos et al (2004)73
Jongsma et al (2018)55
Jongsma et al (2018)55
Jongsma et al (2018)55
Subtotal  (I2=0%–p=0·000)
Reay et al (2009)131
Jongsma et al (2018)55
Gigantesco et al (2012)156
Jongsma et al (2018)55
Sutterland et al (2013)160
Hoeffding et al (2017)202
Subtotal  (I2=99·9%, p=0·000)
First contact
Subtotal  (I2= 98·6%, p=0·000)
Nixon et al (2005)84
Jongsma et al (2018)55
Jongsma et al (2018)55
Jongsma et al (2018)55
Coid et al (2008)123
Jongsma et al (2018)55
Cantor-Graae et al (2005)87
Singh et al (2004)77
Kirkbride et al (2006)6
Bogren et al (2010)46
Cocchi et al (2014)166
Jongsma et al (2018)55
Zandi et al (2010)138
Jongsma et al (2018)55
Smith et al (2006)44
Kirkbride et al (2006)6
Boonstra et al (2008)116
Kirkbride et al (2007)114
Proctor et al (2004)72
Jongsma et al (2018)55
Menezes et al (2007)13
Jongsma et al (2018)55
Jongsma et al (2018)55
Case register
Pelayo-Teran et al (2008)10
Kirkbride et al (2006)6
Payne et al (2006)92
Selten et al (2005)83
Jongsma et al (2018)55
Population register
Combination
Subtotal  (I2= 0%–p=0·000)
Veling et al (2008)120
Markkula et al (2017)53
Baldwin et al (2005)43
France
Italy
Sweden
Spain
Spain
Brazil
England
Spain
Italy
Italy
Netherlands
Denmark
England
France
Spain
Netherlands
England
Italy
Sweden
England
England
Sweden
Italy
England
Netherlands
Netherlands
Canada
England
Netherlands
England
England
Spain
Brazil
England
Spain
Spain
England
Canada
Surinam
France
Netherlands
Finland
Ireland
Paris
Veneto
Madrid
Oviedo
Ribeirao Preto
Santiago
Bologna
Puy-de-Dome
Valencia
Amsterdam
Palermo
London
Cambridgeshire
Gouda and Voorhout
Bristol
Cuenca
Southeast London
Barcelona
Nottingham
Val-de-Marne
18·66 (14·77–23·58)
40·04 (32·92–48·72)
16·28 (13·12–20·20)
20·49 (19·32–21·73)
17·46 (13·80–22·09
14·30 (11·30–18·09
14·73 (13·36–16·25)
17·12 (14·35–20·42)
17·12 (15·22–19·25)
5·21 (3·66–7·41)
7·39 (6·32–8·64)
14·01 (11·75–16·72)
21·76 (19·34–24·47)
55·70 (54·62–56·80)
90·91 (34·79–237·51)
17·44 (14·60–20·83)
12·94 (10·84–15·43)
12·43 (8·56–18·04)
14·01 (10·65–18·44)
42·10 (37·43–47·35)
43·82 (41·31–46·47)
9·68 (8·27–11·32)
37·34 (31·92–43·68)
14·15 (11·87–16·88)
40·45 (33·91–48·25)
36·97 (27·55–49·60)
6·62 (4·93–8·88)
11·94 (10·41–13·70)
14·01 (10·04–19·55)
15·96 (13·38–19·04)
37·71 (36·26–39·22)
14·44 (10·97–19·00)
21·98 (17·37–27·80)
19·30 (16·82–22·14)
17·12 (14·35–20·42)
13·33 (9·01–19·73)
9·97 (8·70–11·44)
57·40 (51·03–64·56)
10·91 (8·97–13·28)
13·74 (11·74–16·07)
13·87 (9·94–19·36)
12·43 (10·62–14·54)
16·78 (13·00–21·65)
26·31 (22·06–31·39)
12·94 (10·84–15·43)
21·76 (19·34–24·47)
148·41 (142·71–154·35)
10·80 (8·54–13·67)
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episode psychosis and non-affective psychotic disorders in 
men and ethnic minority groups, with less evidence of 
such differences for affective psychotic disorders.
The strength of our study is that our search strategy was 
inclusive and based on a previously used strategy with 
good reliability.18 We searched multiple databases without 
restriction by place or language of publication. Although 
individual studies might have been missed, given the size 
of our yield we consider it unlikely that these missing data 
would have substantially altered our main conclusions.
One limitation of our Article was that some citations 
provided incidence estimates from multiple catchment 
areas (notably Jongsma and colleagues, 2018),55 which we 
included as separate estimates in meta-analyses. We 
acknowledge this inclusion might have conservatively 
biased SEs around effect sizes. Nonetheless, it would not 
have affected our observation of substantial interestimate 
heterogeneity in incidence, which was the primary focus 
of our Article. Future studies should consider adopting 
individual-participant data approaches, which account for 
clustering by design.56 We used a previously published, 
clinician-informed algorithm to group estimates into 
major psychotic disorder categories.18 However, for non-
affective disorders particularly, the use of this algorithm 
led to the categorisation of studies that used several 
overlapping diagnostic outcomes (appendix pp 33–34), 
which might have contributed to heterogeneity. Although 
our quality assessment tool was based on epidemiological 
good practice, we acknowledge it might have been skewed 
towards first-contact studies given it is not feasible to 
assess some criteria (ie, blinding) in register-based 
designs. Despite this, our quality assessment aided in 
Figure 4: Incidence of schizophrenia
References from 61 onwards are found in the appendix (pp 35–43). IR=incidence rates. Note: weights are from random effects analysis.
NotesCountry IR (95% CI)
20 40 6080
Overall  (I2=99·8%, p=0·000)
Coid et al (2008)123
Harlap et al (2009)130
Subtotal  (I2=99·8%, p=0·000)
Lasalvia et al (2014)9
Laursen et al (2007)105
First contact
Kirkbride et al (2006)6
Weiser et al (2008)119
Case register
Kim et al (2017)52
Cantor-Graae et al (2005)87
Reay et al (2009)131
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Baldwin et al (2005)43
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Laursen et al (2007)105
Kirkbride et al (2006)6
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Nixon et al (2005)84
Mulé et al (2016)12
Tarricone et al (2012)11
Laursen et al (2007)105
Cohort
Subtotal  (I2=99·9%, p=0·000)
Kirkbride et al (2006)6
Morgan et al (2016)15
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England
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8·17 (6·98–9·55)
33·12 (31·84–34·44)
75·94 (74·47–77·45)
3·35 (2·01–5·58)
4·14 (3·27–5·23)
7·03 (5·45–9·07)
33·12 (31·84–34·44)
59·15 (56·87–61·51)
2·69 (1·36–5·34)
29·08 (23·90–35·37)
43·82 (41·31–46·47)
21·54 (17·03–27·25)
41·03 (23·85–70·57)
7·03 (5·45–9·07)
13·07 (10·95–15·59)
23·34 (19·95–27·30)
38·86 (37·37–40·41)
40·67 (11·95–138·46)
8·17 (5·31–12·57)
27·39 (20·01–37·47)
13·07 (9·83–17·37)
7·03 (5·45–9·07)
12·06 (10·31–14·11)
28·50 (26·35–30·83)
13·74 (13·21–14·28)
68·72 (64·79–72·88)
19·49 (14·53–26·15)
20·29 (18·04–22·82)
34·12 (33·46–34·80)
30·57 (29·98–31·17)
8·17 (7·85–8·49)
18·54 (17·83–19·28)
19·49 (12·18–31·20)
24·05 (17·57–32·90)
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assessing the gaps in the published literature.
The most recent systematic review and meta-analysis 
of all psychotic disorders19 identified substantially fewer 
citations (N=33) than our Article and provided no 
assessment or investigation of heterogeneity, despite 
similar inclusion criteria and time frames. The estimates 
of our more comprehensive review are aligned: we 
found a pooled estimate of non-affective disorders of 
18·7 per 100 000 person-years (95% CI 14·8–23·7) and 
of affective disorders of 4·8 (3·3–6·9) compared with 
their estimates of 22·5 (16·5–28·5) for non-affective and 
7·1 (1·4–12·2) for affective disorders.19 Our findings on 
the excess of psychoses in men were nuanced: the overall 
excess found in both reviews appears to be primarily 
driven by an excess in non-affective disorders in line with 
other meta-analytic evidence.27,28
The median incidence of schizophrenia in our Article 
(21·7 per 100 000 person-years [IQR 5·6–52·0]) was 
higher than in the last major systematic review17 on this 
topic by McGrath and colleagues (15·2 [7·7–43·0]), with 
greater variation around these estimates. The only 
systematic review57 pertaining to mood disorders solely 
synthesised incidence of major depressive disorder and 
as such is not directly comparable to the present Article. 
The excess risk of (non-affective) psychotic disorders in 
migrants and their descendants is long-established,58 
well-reported,20,29 and covered elaborately in one 
publication.30
The present Article presents a varied epidemiological 
landscape, which partly appears to reflect methodological 
differences in study design. We found substantial 
heterogeneity both within and between study designs, 
with incidences of non-affective disorders, schizophrenia, 
and bipolar disorder higher in registry-based studies 
than in first contact studies. Different study designs were 
more common for different outcomes; for instance, a 
large proportion of schizophrenia studies were 
population registers, potentially contributing to this 
pooled estimate being higher than the pooled estimate of 
non-affective disorders (a broader category). Although 
individual studies36,37 have done direct comparisons 
between different study designs, to our knowledge this 
study is the first systematic review to have investigated 
such differences. From a public mental health pers-
pective, our results highlight the importance of parsing 
out potentially causally-relevant signals in geographical 
Figure 5: Incidence of affective disorders
References from 61 onwards are found in the appendix (pp 35–43). IR=incidence rates. Note: weights are from random effects analysis.
NotesCountry IR (95% CI)
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Overall  (l2=99·0%, p=0·000)
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Coid et al (2008)123
Jongsma et al (2018)55
Chiang et al (2016)48
Jongsma et al (2018)55
Subtotal  (l2=0%, p=0·000)
Jongsma et al (2018)55
Jongsma et al (2018)55
Jongsma et al (2018)55
Jongsma et al (2018)55
Jongsma et al (2018)55
Tortelli et al (2014)167
Proctor et al (2004)72
Jongsma et al (2018)55
Jongsma et al (2018)55
Kirkbride et al (2006)6
Singh et al (2004)77
Reay et al (2009)131
Menezes et al (2007)13
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Subtotal  (l2=99·0%, p=0·000)
Jongsma et al (2018)55
Jongsma et al (2018)55
Jongsma et al (2018)55
Jongsma et al (2018)55
Jongsma et al (2018)55
Kirkbride et al (2006)6
Bogren et al (2009)133
Case register
Veen et al (2004)76
England
Ireland
France
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Spain
Taiwan
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Spain
Italy
Brazil
Italy
Italy
France
England
England
Spain
England
England
England
Brazil
Netherlands
Netherlands
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England
France
England
Sweden
Netherlands
Nottingham
Puy−de−Dome
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Bologna
Ribeirao Preto
Veneto
Palermo
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Oviedo
Bristol
Amsterdam
Gouda and Voorhout
Val−de−Marne
Southeast London
Paris
Southeast London
4·55 (3·06–6·77)
8·17 (6·85–9·74)
11·59 (9·16–14·66)
6·17 (3·64–10·48)
1·40 (0·58–3·39)
13·87 (11·63–16·55)
0·90 (0·37–2·16)
1·70 (1·67–1·73)
2·89 (1·63–5·10)
11·36 (8·80–14·66)
0·90 (0·45–1·78)
3·82 (2·74–5·33)
6·62 (5·66–7·74)
2·80 (1·65–4·75)
1·40 (0·93–2·12)
1·35 (0·75–2·43)
11·36 (8·80–14·66)
5·00 (4·03–6·21)
2·61 (1·48–4·61)
5·81 (3·78–8·95)
5·16 (3·77–7·05)
8·67 (7·27–10·34)
5·87 (4·92–7·00)
4·40 (2·95–6·57)
4·31 (2·97–6·25)
5·10 (3·73–6·98)
14·88 (11·99–18·46)
4·01 (2·51–6·43)
4·48 (2·54–7·91)
14·01 (10·86–18·08)
16·95 (10·80–26·60)
3·25 (2·11–5·01)
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variance in incidence from noise generated through 
varying study designs used in different settings; 
individual studies16,55,59 that have done so suggest 
substantive variation in the global burden of psychotic 
disorders remains.
Nevertheless, more research is required to understand 
heterogeneity in incidence produced by different study 
designs. One possible explanation is that register-based 
studies primarily (though not exclusively) originate from 
Scandinavian countries, and higher incidences might 
indicate an association between latitude and psychotic 
disorders (which is well-reported, but poorly under-
stood).31 Alternatively, although registry-based studies 
might ascertain new cases of psychotic disorder across an 
entire (usually secondary and tertiary) health-care system, 
not limited to contact with mental health providers, they 
also rely heavily on diagnoses made in clinical practice. 
Although such diagnoses are reliable,60 first-contact 
studies are often able to include standardised diagnostic 
assessments, which might reduce the number of false 
positives, leading to lower reported incidence. Small 
study effects are not necessarily due to publication bias41 
and in our Article are consistent with the possibility of 
lower incidence rates reported in first contact designs; 
registry-based or insurance database-based studies tended 
to include a larger number of cases (table). However, 
sensitivity analyses (appendix p 32) suggest some within-
type small study effects remained, which might reflect 
real variance between for instance urban (where a large 
number of cases accrue) and rural areas. In this Article, 
we were unable to assess effects of urbanicity, latitude, or 
other socioeconomic variables due to the preponderance 
of country-wide estimates for which no meaningful 
values could be assigned.
The geographical spread of studies in this Article 
remained mostly limited to Europe, Northern America, or 
Australia. One public health implication of our findings is 
the continued dearth of evidence outside of these settings, 
which might have profound consequences; for example, a 
cross-sectional study16 suggested the well established link 
between urbanicity and psychosis might not apply in 
LMICs. To fully understand and provide effective public 
mental health responses to the global burden of psychotic 
disorders, we will re quire methodologically-rigorous and 
culturally-appropri ate epi demiological studies to delineate 
the incidence of psychotic disorders in a broader range of 
Figure 6: Incidence of bipolar disorder
References from 61 onwards are found in the appendix (pp 35–43). IR=incidence rates. Note: weights are from random effects analysis. 
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settings than has thus far been considered. 
Finally, our findings also suggest that developing 
international guidelines for investigation of the incidence 
of psychotic disorders in different settings could help 
minimise methodological heterogeneity in the reporting 
of psychosis incidence across the globe.
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